Developmental Disabilities Modification of the Children’s Global Assessment Scale

National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
Biological Psychiatry (Impact Factor: 10.26). 03/2007; 61(4):504-11. DOI: 10.1016/j.biopsych.2007.01.001
Source: PubMed


Interventions for pervasive developmental disorders (PDD) aim to alleviate symptoms and improve functioning. To measure global functioning in treatment studies, the Children's Global Assessment Scale was modified and psychometric properties of the revised version (DD-CGAS) were assessed in children with PDD.
Developmental disabilities-relevant descriptors were developed for the DD-CGAS, and administration procedures were established to enhance rater consistency. Ratings of clinical case vignettes were used to assess inter-rater reliability and temporal stability. Validity was assessed by correlating the DD-CGAS with measures of functioning and symptoms in 83 youngsters with PDD. Sensitivity to change was assessed by comparing change from baseline to post-treatment with change on the Aberrant Behavior Checklist-Irritability and Clinical Global Impressions-Improvement subscale scores in a subset of 14 children.
Inter-rater reliability (intraclass correlation coefficient [ICC] = .79) and temporal stability (average ICC = .86) were excellent. The DD-CGAS scores correlated with measures of functioning and symptoms with moderate to large effect sizes. Changes on the DD-CGAS correlated with changes on the Aberrant Behavior Checklist-I (r = -.71) and Global Impressions Scale-I (r = -.52). The pre-post DD-CGAS change had an effect size of .72.
The DD-CGAS is a reliable instrument with apparent convergent validity for measuring global functioning of children with PDD in treatment studies.

Download full-text


Available from: Benedetto Vitiello, Oct 03, 2015
36 Reads
  • Source
    • "In the trial, a treatment responder was defined as a rating of 1 (''very much improved'') or 2 (''much improved''), and all other endpoint ratings were considered non-responders. Developmental Disability–Child Global Assessment Scale (DD-CGAS; Wagner et al. 2007). The DD-CGAS is a reliable and valid (test–retest, r = .86; "
    [Show abstract] [Hide abstract]
    ABSTRACT: Comorbid anxiety is common among children with Autism Spectrum Disorder (ASD), and parents of children with ASD are more likely to have anxiety disorders. This study investigated the relationship between parents' state and trait anxiety and parent-reported internalizing and externalizing symptoms among adolescents (n = 30) with ASD, as well as the relationship of parents' anxiety symptoms and adolescent treatment response in the context of a randomized controlled trial. Parental state anxiety correlated with severity of adolescent anxiety, and trait anxiety in parents correlated with parent-reported adolescent internalizing and externalizing symptoms. Also, parents of adolescent treatment responders experienced a decrease in their own trait anxiety. Findings highlight the importance of considering parental anxiety when targeting anxiety among youth with ASD.
    Journal of Autism and Developmental Disorders 12/2012; 43(8). DOI:10.1007/s10803-012-1728-0 · 3.06 Impact Factor
  • Source
    • "Possible explanations of why these associations were not detected in the regression analysis could be that the sample size in our study was too small and that 23% of the sample in this study had an IQ below 70. The CGAS has been criticized for not covering all relevant domains of functioning in children with developmental disabilities (Wagner et al., 2007). It could be that the part of the sample in this study with an IQ under 70 primarily has difficulties related to problems that are common among children with developmental disabilities, and that impairment related to psychiatric symptoms are not the most prominent problem. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous studies indicate that low IQ is a substantial risk factor for developing mental health problems. Based on these results, we hypothesized that IQ may predict some of the variance in clinician-rated severity of children's mental health problems measured with the Children's Global Assessment Scale (CGAS) and Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). The other aims of this study were to examine if there was any difference in the predictive ability of the different IQ scores of the Wechsler Intelligence Scale for Children, Third edition (WISC-III) and to examine if parent-rated measure of child mental health problems could predict the scores on CGAS and HoNOSCA after controlling for IQ, age, and gender. In this study, 132 patients at three outpatient clinics in North Norway were assessed with the parent version of the Strength and Difficulties Questionnaire (SDQ), HoNOSCA, CGAS, and with the WISC-III. Hierarchical regression analyses were conducted with HoNOSCA and CGAS as dependent variables. Demographics, WISC-III IQ scores, and SDQ were entered as independent variables. The model with HoNOSCA as the dependent variable predicted 25% of the total variance. The WISC-III full-scale IQ predicted an additional 6% of the variance. The analyses with CGAS as the dependent variable gave no significant results. When a patient has a high HoNOSCA score, an intelligence test in addition to an evaluation of symptoms on mental health should be considered. Future research ought to examine whether HoNOSCA's ability to detect change might be affected by patients IQ.
    British Journal of Clinical Psychology 06/2012; 51(2):185-96. DOI:10.1111/j.2044-8260.2011.02023.x · 1.90 Impact Factor
  • Source
    • "Because of the possible recall bias, we mainly reported current diagnoses. Recently, a modification of K-SADS-PL (Autism Comorbidity Interview-Present and Lifetime Version; ACI-PL; Leyfer et al. 2006) for children and adolescents with autism and a CGAS modification (Developmental Disability-Child Global Assessment Scale; DD-CGAS; Wagner et al. 2007) for children with PDDs have been developed. However, this study was drawn up and performed before these modified instruments were available. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We assessed the validity and determined cut-off scores for the Finnish Autism Spectrum Screening Questionnaire (ASSQ). A population sample of 8-year-old children (n = 4,408) was rated via the ASSQ by parents and/or teachers, and a subgroup of 104 children was examined via structured interview, semi-structured observation, IQ measurement, school observation, and medical records. Autism spectrum disorders (ASDs) were diagnosed following DSM-IV-TR criteria. A search for hospital-registered ASDs was performed. For Finnish higher-functioning primary school-aged, 7- to 12-year-olds, the optimal cut-off score was 30 in clinical settings and 28 in total population screening using summed ASSQ scores of parents' and teachers' ratings. Determining appropriate cut-off scores in ASD screening in different languages and in different cultures is of utmost importance.
    Journal of Autism and Developmental Disorders 03/2012; 42(10):2162-80. DOI:10.1007/s10803-012-1464-5 · 3.06 Impact Factor
Show more